
Enzyre
Our technology will revolutionize blood coagulation management.
$11.87M Series A ·
Source: startupintros.com
Latest round on record: Series A, January 2023, amount undisclosed.
All 2 rounds ↓Signals
About Enzyre
The ENZYSYSTEM enables real near patient blood coagulation analysis, with the measured data being effortlessly made available to the treating physician, irrespective of his or her physical location.
Funding rounds
- Series A · amount undisclosedSource: fundraisingfox.com
- Series A · $11.87MSource: startupintros.com
- Website created
Companies like Enzyre
LLevisonics
VVarmXSeries B+ · May 2023
SSoihtu DTx
CCerebroSonic
PPrado$5.75M Seed · Nov 2022UUpperline Health$58M · Jun 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/enzyre (get a free API key).